021-51111890
购物车（0）
sales@molnova.cn
Etidocaine Hydrochloride
CAS No. 36637-19-1
Etidocaine Hydrochloride ( Duranest | W-19053 | W 19053 | W19053 )
产品货号. M27981 CAS No. 36637-19-1
盐酸依多卡因是一种长效麻醉剂和电压门控钠通道阻滞剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥2373 | 有现货 |
|
| 10MG | ￥3548 | 有现货 |
|
| 25MG | ￥5638 | 有现货 |
|
| 50MG | ￥7962 | 有现货 |
|
| 100MG | ￥10692 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Etidocaine Hydrochloride
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述盐酸依多卡因是一种长效麻醉剂和电压门控钠通道阻滞剂。
-
产品描述Etidocaine Hydrochloride is a long-acting anesthetic and a blocker of the voltage-gated sodium channel.
-
体外实验IGL-EDC formulations can induce a significant increase in human fibroblasts survival. Cell Viability Assay Cell Line:Human fibroblasts cells Concentration:0, 4, 8, 16, 24 mM Incubation Time:4, 6 and 24 h Result:Showed that cell survival decreased in a (EDC) concentration with time-dependent manner.
-
体内实验Etidocaine (spinal injection, 0.0075%, once) does not show postinjection neurologic deficit. Animal Model:Adult Swiss Webster male mice Dosage:0.0075% Administration:Etidocaine(spinal injection, 0.0075%, once)Result:Did not show postinjection neurologic deficit.
-
同义词Duranest | W-19053 | W 19053 | W19053
-
通路Membrane Transporter/Ion Channel
-
靶点Sodium Channel
-
受体D2|5-HT2A
-
研究领域——
-
适应症——
化学信息
-
CAS Number36637-19-1
-
分子量313.89
-
分子式C17H30ClN2O
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 62.5 mg/mL (199.76 mM)
-
SMILESCl.CCC[NH](CC)C(CC)C(=O)Nc1c(C)cccc1C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Yamazaki S, et al. Comparison of prediction methods for in vivo clearance of (S,S)-3-[3-(methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride, a dopamine D2 receptor antagonist, in humans. Drug Metab Dispos. 2004 Apr;32(4):398-404.
产品手册
关联产品
-
Tocainide hydrochlor...
Tocainide hydrochloride (2-amino-n-(2,6-dimethylphenyl)propanamide hydrochloride) is a sodium channel blocker. It blocks the sodium channels in the pain-producing foci in the nerve membranes.
-
AZD-1305
AZD-1305 是一种新型抗心律失常药，主要阻断 Ikr 的快速成分。
-
Oxethazaine
Oxethazaine (Oxetacaine) 是芬特明的酸性前体，是一种具有耐酸性和口服活性试剂。Oxethazaine (Oxetacaine) 具有缓解消化性溃疡疾病或食管炎引起的疼痛的潜力。
